Review
doi: 10.1016/j.bbcan.2005.10.001.
Epub 2005 Oct 25.
The KRAS oncogene: past, present, and future
Affiliations
- PMID: 16269215
- DOI: 10.1016/j.bbcan.2005.10.001
Item in Clipboard
Review
The KRAS oncogene: past, present, and future
Biochim Biophys Acta.
.
No abstract available
Similar articles
-
Screening of mutations in the ras family of oncogenes by polymerase chain reaction-based ligase chain reaction.Methods Mol Med. 2003;74:187-200. doi: 10.1385/1-59259-323-2:187. Methods Mol Med. 2003. PMID: 12415694 No abstract available.
-
Oncogenic activating mutations are associated with local copy gain.Mol Cancer Res. 2009 Aug;7(8):1244-52. doi: 10.1158/1541-7786.MCR-08-0532. Epub 2009 Aug 11. Mol Cancer Res. 2009. PMID: 19671679
-
KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer.Clin Cancer Res. 2011 Mar 1;17(5):1122-30. doi: 10.1158/1078-0432.CCR-10-1720. Epub 2011 Jan 14. Clin Cancer Res. 2011. PMID: 21239505
-
Methods for isolation and genetic analysis of circulating tumor DNA in patient plasma.Methods Mol Med. 2003;85:257-62. doi: 10.1385/1-59259-380-1:257. Methods Mol Med. 2003. PMID: 12710213 Review. No abstract available.
-
The interplay between ras oncogenes and tumor suppressor genes in experimental carcinogenesis.Immunol Ser. 1990;51:75-88. Immunol Ser. 1990. PMID: 2128916 Review. No abstract available.
Cited by
-
Prognostic and predictive roles of KRAS mutation in colorectal cancer.Int J Mol Sci. 2012 Sep 25;13(10):12153-68. doi: 10.3390/ijms131012153. Int J Mol Sci. 2012. PMID: 23202889 Free PMC article. Review.
-
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome.J Natl Cancer Inst. 2012 Feb 8;104(3):228-39. doi: 10.1093/jnci/djr523. Epub 2012 Jan 13. J Natl Cancer Inst. 2012. PMID: 22247021 Free PMC article.
-
Changes in gene-expression profiles of colon carcinoma cells induced by wild type K-ras2.World J Gastroenterol. 2007 Sep 14;13(34):4620-5. doi: 10.3748/wjg.v13.i34.4620. World J Gastroenterol. 2007. PMID: 17729418 Free PMC article.
-
Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer.Front Oncol. 2022 Jan 5;11:780655. doi: 10.3389/fonc.2021.780655. eCollection 2021. Front Oncol. 2022. PMID: 35070984 Free PMC article. Review.
-
Current concepts on the molecular pathology of non-small cell lung carcinoma.Semin Diagn Pathol. 2014 Jul;31(4):306-13. doi: 10.1053/j.semdp.2014.06.008. Epub 2014 Jun 12. Semin Diagn Pathol. 2014. PMID: 25239274 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
